{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:43:14Z","timestamp":1772574194886,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To integrate relevant clinical data of multicatheter accelerated partial breast irradiation (mAPBI) for reaching a comprehensive conclusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We did 3 meta-analyses for clinical outcomes including 1740 women from 4 articles, for acute radiotherapy (RT)-associated toxicity including 1255 patients from 5 articles, and for late RT-related toxicity involving 1565 patients from 9 papers. Clinical outcomes analyses were stratified by molecular subtypes, lymph nodes status, receptor status, and human epidermal growth factor receptor 2 (HER2) status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>For the Luminal A\/B phenotypes, the disease relapse and failure in survival significantly decreased when compared with triple negative (TN)\/HER2-amplified subtypes (<jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.00001). The 5-year regional nodal recurrence (RNR), 5-year distant metastasis-free survival (DMFS) and 5-year disease free-survival (DFS) of TN patients were significantly superior to HER2-overexpression patients (<jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.00001). The 5-year cause-specific survival (CSS), 5-year DMFS and 5-year overall survival (OS) in women with lymph nodes-negative were significantly improved versus patients with lymph nodes-positive (<jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.0001). Conversely, the positive status of HER2 compared with negative one significantly increased the rate of local recurrence (LR) (<jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.02). For acute toxicity, the morbidity of dermatitis was significantly higher than hematoma and implant infection (<jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.01, <jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.0001, respectively). For late toxicity, the occurrences of fibrosis (32%) and telangiectasia (14%) were significantly higher than other complications (<jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>HER2-enriched subtype compared with other subtypes has significantly increased disease relapse and failure in survival. HER2-positive status is positively associated with an increased incidence of LR. Dermatitis is the most common acute RT-related toxicity and fibrosis is the first rife late RT-related toxicity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014407","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:56:52Z","timestamp":1549529812000},"page":"e14407","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review of clinical outcomes and radiotherapy-associated toxicity in multicatheter accelerated partial breast irradiation"],"prefix":"10.1097","volume":"98","author":[{"given":"Yang","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Oncology, The PLA Navy Anqing Hospital, Anqing, Anhui Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[{"name":"Breast Center B ward, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Anhui Medical University, Hefei, Anhui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiu","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Anhui Medical University, Hefei, Anhui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Song","sequence":"additional","affiliation":[{"name":"Breast Center B ward, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01607043","article-title":"An original stereomicroscopic analysis of the mammary glandular tree","volume":"421","author":"Faverly","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0360-3016(93)90382-6","article-title":"Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting","volume":"27","author":"Haffty","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1006462328544","article-title":"Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age","volume":"62","author":"Imamura","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(19950701)76:1<32::AID-CNCR2820760106>3.0.CO;2-R","article-title":"Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems","volume":"76","author":"Ohtake","year":"1995","journal-title":"Cancer"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00000421-198712000-00001","article-title":"Breast cancer. Experiences with conservation therapy","volume":"10","author":"Clark","year":"1987","journal-title":"Am J Clin Oncol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1011136326943","article-title":"Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial","volume":"12","author":"Veronesi","year":"2001","journal-title":"Ann Oncol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jnci\/82.4.277","article-title":"Sector resection with or without postoperative radiotherapy for stage, I., breast cancer: a randomized, trial","volume":"82","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1309\/8941VDAJMKY2GCLX","article-title":"Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients","volume":"120","author":"Goldstein","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ncponc0845","article-title":"Accelerated partial breast irradiation using multicatheter brachytherapy","volume":"4","author":"Sarin","year":"2007","journal-title":"Nature Clin Pract Oncol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncponc0071","article-title":"Partial-breast treatment for early breast cancer: emergence of a new paradigm","volume":"2","author":"Sarin","year":"2005","journal-title":"Nature Clin Pract Oncol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brachy.2011.06.001","article-title":"A comparison of brachytherapy techniques for partial breast irradiation","volume":"11","author":"Hepel","year":"2012","journal-title":"Brachytherapy"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5114\/jcb.2018.74137","article-title":"Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort","volume":"10","author":"Wadasadawala","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/COC.0000000000000334","article-title":"Outcomes of node-positive breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) experience","volume":"41","author":"Kamrava","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.brachy.2016.08.012","article-title":"Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry of Multicatheter Interstitial Sites research group","volume":"15","author":"Anderson","year":"2016","journal-title":"Brachytherapy"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.radonc.2015.03.002","article-title":"Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy","volume":"115","author":"Budrukkar","year":"2015","journal-title":"Radiother Oncol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.radonc.2017.07.015","article-title":"Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study","volume":"124","author":"Aristei","year":"2017","journal-title":"Radiother Oncol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2006.08.028","article-title":"Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial","volume":"82","author":"Ott","year":"2007","journal-title":"Radiother Oncol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/jcb.2018.73994","article-title":"Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results","volume":"10","author":"Latorre","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.brachy.2017.11.008","article-title":"Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: early results of the Single-Fraction Elderly Breast Irradiation (SiFEBI) Phase I\/II trial","volume":"17","author":"Hannoun-L\u00e9vi","year":"2018","journal-title":"Brachytherapy"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijrobp.2010.01.020","article-title":"Accelerated partial breast irradiation: 5-year results of the German\u2013Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery","volume":"80","author":"Strnad","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.brachy.2017.06.006","article-title":"Accelerated partial breast irradiation for elderly women with early breast cancer: a compromise between whole breast irradiation and omission of radiotherapy","volume":"16","author":"Sumodhee","year":"2017","journal-title":"Brachytherapy"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2014.08.341","article-title":"Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial","volume":"90","author":"Cuttino","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2013.03.026","article-title":"Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group","volume":"108","author":"Hannoun-Levi","year":"2013","journal-title":"Radiother Oncol"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2010.01.019","article-title":"Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-5-56","article-title":"Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity","volume":"5","author":"Yeo","year":"2010","journal-title":"Radiat Oncol (London, England)"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2010.07.011","article-title":"Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy","volume":"100","author":"Lettmaier","year":"2011","journal-title":"Radiother Oncol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","article-title":"5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet (London, England)"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2011.03.011","article-title":"Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis","volume":"100","author":"Shah","year":"2011","journal-title":"Radiother Oncol"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.ijrobp.2011.05.066","article-title":"Impact of lymph node status on clinical outcomes after accelerated partial breast irradiation","volume":"82","author":"Shah","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.05.039","article-title":"Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity","volume":"88","author":"Vargo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ijrobp.2007.12.005","article-title":"Clinical outcome analysis in \u201chigh-risk\u201d versus \u201clow-risk\u201d patients eligible for national surgical adjuvant breast and bowel B-39\/radiation therapy oncology group 0413 trial: five-year results","volume":"70","author":"Patel","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1245\/s10434-013-3015-5","article-title":"Locoregional recurrence following accelerated partial breast irradiation for early-stage invasive breast cancer: significance of estrogen receptor status and other pathological variables","volume":"20","author":"Cannon","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.02.061","article-title":"Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy","volume":"82","author":"Hattangadi-Gluth","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2016.06.019","article-title":"GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance","volume":"120","author":"Ott","year":"2016","journal-title":"Radiother Oncol"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0360-3016(03)00120-2","article-title":"Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience","volume":"56","author":"Arthur","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0360-3016(01)01547-4","article-title":"The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy","volume":"50","author":"Baglan","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.21681","article-title":"Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma","volume":"106","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0360-3016(03)00071-3","article-title":"Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant","volume":"56","author":"Lawenda","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-9098(199708)65:4<263::AID-JSO7>3.0.CO;2-3","article-title":"Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study","volume":"65","author":"Perera","year":"1997","journal-title":"J Surg Oncol"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0360-3016(02)02824-9","article-title":"Preliminary results of a phase I\/II study of HDR brachytherapy alone for T1\/T2 breast cancer","volume":"53","author":"Wazer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2006.08.028","article-title":"Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial","volume":"82","author":"Ott","year":"2007","journal-title":"Radiother Oncol"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2004.05.012","article-title":"High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study","volume":"60","author":"Polgar","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02573889","article-title":"Long-term complications associated with breast-conservation surgery and radiotherapy","volume":"9","author":"Meric","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0360-3016(94)90312-3","article-title":"Dose and volume effects on fibrosis after breast conservation therapy","volume":"30","author":"Borger","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:08:23Z","timestamp":1694722103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014407","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}